Michael Wyand Insider Trading $CRXX EPIRUS Biopharmaceuticals, Inc.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Michael Wyand.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Michael Wyand. Michael Wyand is Chief Technical Officer in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and President and COO in EPIRUS Biopharmaceuticals, Inc. ($CRXX) and See Remarks in EPIRUS Biopharmaceuticals, Inc. ($CRXX).
Michael Wyand in EPIRUS Biopharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Michael Wyand: President and COO, Chief Technical Officer, See Remarks
Holdings: 32,661 shares
Latest Transaction: May 31 2016
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of Michael Wyand in EPIRUS Biopharmaceuticals, Inc.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 31 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | President and COO | Option Exercise | A | 0.00 | 280,000 | 0 | 280,000 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | M | 0.00 | 2,608 | 0 | 7,824 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | M | 0.00 | 1,044 | 0 | 0 | |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Payment of Exercise | F | 2.80 | 1,379 | 3,861 | 32,661 | 34 K to 32.7 K (-4.05 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Buy | M | 0.00 | 2,608 | 0 | 34,040 | 31.4 K to 34 K (+8.30 %) |
| Mar 01 2016 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Buy | M | 0.00 | 1,044 | 0 | 31,432 | 30.4 K to 31.4 K (+3.44 %) |
| Nov 03 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | A | 5.55 | 58,247 | 323,271 | 58,247 | |
| Sep 14 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | M | 1.00 | 4,538 | 4,538 | 2,269 | |
| Sep 14 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | M | 1.00 | 4,209 | 4,209 | 3,880 | |
| Sep 14 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Buy | M | 1.00 | 8,747 | 8,747 | 30,388 | 21.6 K to 30.4 K (+40.42 %) |
| Apr 03 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | Chief Technical Off ... | Option Exercise | A | 8.40 | 20,000 | 168,000 | 20,000 | |
| Mar 02 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 0.00 | 10,432 | 0 | 10,432 | |
| Mar 02 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 0.00 | 1,044 | 0 | 1,044 | |
| Mar 02 2015 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 10.53 | 79,461 | 836,724 | 79,461 | |
| Jul 17 2014 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 7.40 | 86,448 | 639,715 | 86,448 | |
| Jul 17 2014 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 1.00 | 6,807 | 6,807 | 6,807 | |
| Jul 17 2014 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 1.00 | 8,089 | 8,089 | 8,089 | |
| Jul 17 2014 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Option Exercise | A | 1.00 | 20,209 | 20,209 | 20,209 | |
| Jul 17 2014 | CRXX | EPIRUS Biopharmace ... | Wyand Michael | See Remarks | Grant | A | 0.00 | 21,641 | 0 | 21,641 | 0 to 21.6 K |
Page: 1